
Tuesday, December 16, 2014 8:46:03 PM
Recent TECH News
- Bio-Techne and Spear Bio Announce Strategic Partnership to Advance Therapeutic Development with Ultrasensitive Biomarker Detection • PR Newswire (US) • 07/15/2025 11:00:00 AM
- Bio-Techne's Simple Western™ Technology Utilized in Recent FDA Approval of ZEVASKYN™ Cell-Based Gene Therapy • PR Newswire (US) • 07/14/2025 11:00:00 AM
- Bio-Techne and USP Announce Collaboration to Accelerate Monoclonal Antibody and Gene Therapy Product Development • PR Newswire (US) • 06/24/2025 11:00:00 AM
- ScaleReady Announces a G-Rex® Grant has been awarded to Immuneel Therapeutics • PR Newswire (US) • 06/10/2025 11:00:00 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/09/2025 08:19:36 PM
- Form SD - Specialized disclosure report • Edgar (US Regulatory) • 05/30/2025 08:30:27 PM
- Bio-Techne to Present at Investor Conferences • PR Newswire (US) • 05/29/2025 11:00:00 AM
- ScaleReady awards multiple G-Rex® Grants to leading investigators at the University of Southern California (USC) and the Children's Hospital of Los Angeles (CHLA) • PR Newswire (US) • 05/14/2025 11:00:00 AM
- Bio-Techne to Showcase Next-Generation Solutions for Gene and Cell Therapy at American Society of Gene & Cell Therapy 2025 • PR Newswire (US) • 05/12/2025 11:00:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/08/2025 08:30:29 PM
- Kytopen and Bio-Techne Collaborate on an Integrated Cellular Engineering Workflow to Expedite Cell Therapy Manufacturing • PR Newswire (US) • 05/08/2025 01:30:00 PM
- Bio-Techne to Present at the BofA Securities 2025 Health Care Conference • PR Newswire (US) • 05/08/2025 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2025 10:30:11 AM
- BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS • PR Newswire (US) • 05/07/2025 10:30:00 AM
- BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM • PR Newswire (US) • 05/07/2025 10:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2025 08:30:10 PM
- ScaleReady awards a $300,000 G-Rex® Grant to A2 Biotherapeutics, Inc. • PR Newswire (US) • 05/06/2025 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/05/2025 08:18:21 PM
- ScaleReady Announces March Biosciences as Recipient of G-Rex® Grant to Advance Manufacturing of Novel CAR-T Cell Therapy • PR Newswire (US) • 04/29/2025 11:00:00 AM
- Bio-Techne Announces Early Access Program for Next-Generation Spatial Protein Proximity Detection • PR Newswire (US) • 04/24/2025 11:00:00 AM
- Bio-Techne to Showcase Cutting-Edge Solutions at the 2025 American Association for Cancer Research (AACR) Annual Meeting • PR Newswire (US) • 04/23/2025 11:00:00 AM
- Bio-Techne to Host Conference Call on May 7, 2025, to Announce Third Quarter Fiscal 2025 Financial Results • PR Newswire (US) • 04/15/2025 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/07/2025 08:25:38 PM
- Leica Biosystems and Bio-Techne Expand Partnership to Enable Protease-Free Workflows for Automated Spatial Multiomics on the BOND RX Research Staining Instrument • PR Newswire (US) • 04/02/2025 11:00:00 AM
- Bio-Techne Announces New Customer Experience Centre in Düsseldorf, Germany • PR Newswire (US) • 03/26/2025 11:00:00 AM
Nightfood's FHVH to Pioneer AI-Driven Culinary Education in $32.5 Billion US Market • NGTF • Jul 15, 2025 8:30 AM
The Crypto Company (OTC: CRCW) Joins New OTCID Market Tier, Marking Commitment to Innovation, Transparency, and Strategic Growth • CRCW • Jul 15, 2025 8:19 AM
Avant Technologies and JV Partner, Ainnova, Complete Pivotal Meeting with U.S. FDA • AVAI • Jul 15, 2025 8:00 AM
HealthLynked Engages Meridian Group to Accelerate Strategic Partnerships and Revenue Growth • HLYK • Jul 15, 2025 8:00 AM
One World Products Acquires Eco Bio Plastics, Advancing U.S. Manufacturing and Sustainable Packaging Innovation • OWPC • Jul 15, 2025 7:44 AM
Branded Legacy Inc. Announces Leadership Transition and Pending Merger with Innovative Addiction Therapeutics Company Projecting $40 Million in First-Year Revenue • BLEG • Jul 14, 2025 1:23 PM